Izotropic Receives Response From U.S. FDA
Izotropic Provides Regulatory and Operational Updates
Izotropic Completes Pre-Submission Meeting With U.S. FDA
Izotropic Confirms FDA Pre-Submission Meeting Date
Izotropic Closes Non-Brokered Private Placement
Izotropic Modifies Market Approval Pathway & Strategy
Izotropic CEO Resigns
Izotropic Establishing Engineering and Development Facility in the USA
No Data